Citigroup’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.27K Buy
2,194
+1,195
+120% +$6.45K ﹤0.01% 5115
2025
Q4
$7.92K Sell
999
-894
-47% -$5.71K ﹤0.01% 5126
2025
Q3
$6.51K Sell
1,893
-12,923
-87% -$48.1K ﹤0.01% 5153
2025
Q2
$61.2K Sell
14,816
-10,538
-42% -$35.2K ﹤0.01% 4658
2025
Q1
$60.8K Sell
25,354
-3,207
-11% -$9.03K ﹤0.01% 4825
2024
Q4
$104K Buy
28,561
+3,036
+12% +$13.8K ﹤0.01% 4819
2024
Q3
$161K Buy
25,525
+17,755
+229% +$119K ﹤0.01% 4495
2024
Q2
$51.8K Buy
7,770
+4,015
+107% +$23.7K ﹤0.01% 4558
2024
Q1
$19.8K Buy
3,755
+477
+15% +$2.24K ﹤0.01% 5033
2023
Q4
$16.9K Buy
3,278
+3,137
+2,225% +$9.68K ﹤0.01% 5039
2023
Q3
$475 Sell
141
-7,801
-98% -$51.2K ﹤0.01% 5216
2023
Q2
$65.8K Buy
7,942
+6,230
+364% +$56.1K ﹤0.01% 4479
2023
Q1
$15K Buy
1,712
+637
+59% +$7.07K ﹤0.01% 4602
2022
Q4
$13.1K Buy
1,075
+682
+174% +$6.49K ﹤0.01% 4745
2022
Q3
$2K Sell
393
-1,233
-76% -$10.4K ﹤0.01% 5530
2022
Q2
$14K Sell
1,626
-4,420
-73% -$38.9K ﹤0.01% 5200
2022
Q1
$70K Sell
6,046
-4,228
-41% -$65.1K ﹤0.01% 4587
2021
Q4
$181K Buy
10,274
+7,111
+225% +$156K ﹤0.01% 4415
2021
Q3
$72K Buy
+3,163
New +$104K ﹤0.01% 4554

Other funds holding SGHT

Citigroup's SGHT Position: Q1 2026 in Review

Citigroup increased its Sight Sciences (SGHT) stake by 120% in Q1 2026, buying an estimated $6.45K and bringing the position to 2,194 shares worth $8.27K. The position accounts for ﹤0.01% of the portfolio, ranked #5115.

Citigroup first reported a position in SGHT in Q3 2021 and has held it in 19 quarters since. The position peaked at $181K in Q4 2021. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Citigroup held 2,194 shares of Sight Sciences worth $8.27K as of Q1 2026.
  • Citigroup bought 1,195 Sight Sciences shares in Q1 2026, an estimated $6.45K.
  • Sight Sciences made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5115 holding.
  • Citigroup first reported a position in Sight Sciences in Q3 2021 and has held it in 19 quarters since.
  • Citigroup's Sight Sciences position peaked at $181K in Q4 2021.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.